In comparison to [177Lu]Lu-PSMA I&T, [19F]F/[177Lu]Lu-rhPSMA-7.3 emerged as a viable candidate for clinical translation, given its analogous clearance kinetics and comparable radiation dosage to healthy organs, combined with enhanced tumor uptake and retention. Here, FOLH1 is linked to neoplasm.